科研成果详情

在基于物联网的医疗环境下,RFID技术能够对患者的用药过程进行自动监控,大大提高了患者用药的安全性.但由此而产生的患者隐私信息泄露以及用药记录伪造一直是RFID安全协议的研究热点.提出了一种具有阅读器信息保护机制的智能用药方案（IMRIP）,该方案将认证技术与群证明技术相结合,提供安全可靠的患者用药记录,并对RFID阅读器中的医疗信息进行隐藏,能够在阅读器被攻击者获取后,仍能保证患者隐私信息不被泄露.方案的协议进行安全与性能分析表明,相对于其它方案,IMRIP方案能够对患者隐私提供进一步的保护,并且符合EPC C1G2的要求,能够直接应用于现有的RFID系统中. 

In the healthcare environment based on the Internet of things (IOT), the RFID technology can greatly improve the drug security of inpatient by automatically monitoring the medication process of inpatient. But the disclosure of the inpatient privacy information and the forgery of drug administration are research focus in recent literature. In this paper, an Intelligent Medication scheme with the Reader Information Protection (IMRIP) is proposed. The scheme combine authentication technology with grouping-proof, provide the security and reliability of medication record, concealing the medication information in the RFID Readers in order to preserve the information security even when the attackers compromise the Readers. According to the security and performance analyses, IMRIP can more effectively preserve inpatient privacy information compared to existing alternatives. In addition, IMRIP conforms to the EPC C1G2 Standard, and thus can be applied to current RFID Systems.